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Decellularized tissuea b s t r a c t
Congenital diaphragmatic hernia (CDH) is a neonatal defect in which the diaphragm muscle does not
develop properly, thereby raising abdominal organs into the thoracic cavity and impeding lung develop-
ment and function. Large diaphragmatic defects require correction with prosthetic patches to close the
malformation. This treatment leads to a consequent generation of unwelcomed mechanical stress in
the repaired diaphragm and hernia recurrences, thereby resulting in high morbidity and significant mor-
tality rates. We proposed a specific diaphragm-derived extracellular matrix (ECM) as a scaffold for the
treatment of CDH. To address this strategy, we developed a new surgical CDH mouse model to test the
ability of our tissue-specific patch to regenerate damaged diaphragms. Implantation of decellularized
diaphragmatic ECM-derived patches demonstrated absence of rejection or hernia recurrence, in contrast
to the performance of a commercially available synthetic material. Diaphragm-derived ECM was able to
promote the generation of new blood vessels, boost long-term muscle regeneration, and recover host
diaphragmatic function. In addition, using a GFP + Schwann cell mouse model, we identified re-
innervation of implanted patches. These results demonstrated for the first time that implantation of a
tissue-specific biologic scaffold is able to promote a regenerating diaphragm muscle and overcome issues
commonly related to the standard use of prosthetic materials.
Statement of significance
Large diaphragmatic hernia in paediatric patients require application of artificial patches to close the con-
genital defect. Theuseof amuscle-specificdecellularized scaffold in substitutionof currentlyused synthetic
materials allows newblood vessel growth and nerve regeneration inside the patch, supporting newmuscle
tissue formation. Furthermore, the presence of a tissue-specific scaffold guaranteed long-term muscle
regeneration, improving diaphragm performance to almost complete functional recovery. We believe that
diaphragm-derived scaffold will be key player in future pre-clinical studies on large animal models.
 2019 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).rvation
2 C. Trevisan et al. / Acta Biomaterialia xxx (xxxx) xxx1. Introduction repercussion on nerve attraction, muscle maturation, and func-Congenital diaphragmatic hernia (CDH) is a severe neonatal
defect with an incidence of 1/2500–3000 births, accounts for
approximately 8% of the known major congenital anomalies, and
possesses important socioeconomic impact [1–3]. In CDH, defect
in diaphragm development leads to herniation of abdominal
organs into the thoracic cavity and partial failure in lung develop-
ment. The consequent lung hypoplasia is the cause of the 50%
neonatal mortality and long-term morbidity associated with CDH
[4]. Despite the severity of the disease, the genetic and cellular eti-
ology of this birth defect is not yet completely understood [5–7].
Regardless of the origin of CDH, infants with this defect undergo
surgery early after birth to repair the defect and position the
abdominal organs back in their anatomical site. Numerous recon-
structive techniques of closure have been described using prerenal
fascia, rib structures, and various thoracic and abdominal wall
muscle flaps [8–10]. Other materials including absorbable and
nonabsorbable meshes have also been used. Currently, the implan-
tation of prosthetic materials, especially of expanded polytetraflu-
oroethylene (ePTFE) patches, has become the standard procedure
to close up large defects in children with CDH [11]. Unfortunately,
these materials face the major issues of lack of growth and integra-
tion with the surrounding muscle with an associated high rate of
hernia recurrence (up to 40%). Moreover, several long-term prob-
lems remain to be solved after this kind of surgery: common
reported outcomes are severe gastro-esophageal reflux with a need
for fundoplication (9–24%), small bowel obstruction (5–37%), and
chest wall deformities (6–67%) [12–14].
In recent years, it has been suggested that transplantation of
scaffolds composed of extracellular matrix (ECM) proteins pro-
motes repair of injured skeletal muscle by providing a structural
and biochemical mold [15]. For congenital muscle defect treat-
ment, research has documented the use of biological scaffolds
composed of a sheet of acellular matrix (i.e., Surgisis) that can
provide the desired support and reduce the occurrence of compli-
cations resulting from prosthetic and nonabsorbable implants. In
preclinical studies, these scaffolds seemed to be an alternative to
ePTFE [16]; however, large clinical studies failed to show improve-
ment in the recurrence rate when acellular matrixes were used
[16,17]. If recurrences after ePTFE implantation are due to the
imbalance between the growth of the infant and the presence of
a permanent material, re-herniation for acellular patches may be
related to a too rapid degradation of the construct. A tissue-
engineered system capable of restoring near-normal mature mus-
cle, vasculature, and ECM composition in the defective diaphragm
has yet to be achieved. Moreover, attaining de novo innervation of
regenerated myofibers remains a critical step for functional
restoration of skeletal muscle injuries or defects. All these matters
prompt the need for alternative scaffolds that are more resistant to
degradation leastwise defect occlusion and complete tissue
regeneration.
In this scenario, we investigated the use of a tissue-specific scaf-
fold using decellularized diaphragm muscle. We previously
described how such decellularized ECM (dECM) displays important
biological features, from pro-angiogenic properties [18] to the
attraction and activation of myogenic progenitor cells upon
implantation in noninjured models [19]. In this original work, we
describe how the dECM obtained from decellularization of murine
diaphragms efficiently supported muscle re-growth and restora-
tion by using a surgical model of large-defect diaphragmatic hernia
in mice published for the first time. Long-term analyses demon-
strated increased and prolonged local myogenic activity when
implanting patches of decellularized diaphragm with regard to
patches of currently used prosthetic material, with importantPlease cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta Biomational recovery, supporting possible translation in future clinical
practice for the treatment of diaphragmatic defects.2. Material and methods
Additional details relating to materials and methodology are
provided in Supplementary information.2.1. Animals
All surgical procedures and animal husbandry were carried out
in accordance with University of Padova’s Animal care and Use
Committee (protocol number 67/2011 approved on 21 September
2011, and 1103/2016-PR approved on 15 November 2016) and
were approved by the Ministry of Health in accordance with the
Italian Law on the use of experimental animals (DLgs. 26/2014).
The animals used as donors were 12-week-old C57BL/6j male
and female, while the recipients were 12-week-old BALB/c male
and female (n = 78).2.2. Decellularization
Diaphragm muscles were treated with three cycles of the
detergent-enzymatic treatment (DET) as previously described
[19]. Briefly: samples were washed 2 times in 1X sterile
phosphate-buffered saline (PBS, Gibco-Fisher Scientific) and then
placed in deionized water (the first step of the decellularization
process). Each DET cycle involved deionized water at 4 C for
24 h, 4% sodium deoxycholate (Sigma) at room temperature (RT)
for 4 h, and 2000 kU DNase-I (Sigma) in 1 M NaCl (Sigma) at RT
for 3 h, for a total of 3 consecutive DET cycles.2.3. Surgical model
BALB/c mice were operated in general anesthesia. After a med-
ian superior incision, a 3x5 mm hole was surgically created in the
left side of the native diaphragm. Afterwards, the defect was closed
using either dECM or ePTFE as control. Organs were then reposi-
tioned into the abdominal cavity, the abdominal wall was closed
in two layers, and the animals were left to wake up under a heating
lamp (see Supplementary Fig. 1). Survived mice were euthanized
by cervical dislocation at 2 (n = 8), 5 (n = 7), 15 (n = 8), 30 (n = 8),
and 90 (n = 10) days postsurgery. Complete methodology is pro-
vided in the supplementary materials.
A transgenic mouse expressing cytosolic eGFP under the S100B
protein [20] was used to analyze Schwann cell migration and nerve
attraction. These mice were analyzed only after 90 days post-
surgery (n = 9).2.4. Ultrasonography
After 30 and 90 days from surgery, thoracic and abdominal sub-
costal ultrasonography was performed for all the animals using a
high-resolution echo machine with a 30 MHz probe (Vevo 2100
VisualSonics, Toronto, Canada). Untreated mice were analyzed as
control (Ctrl). Animals were chest shaved and anesthetized with
3% isoflurane; temperature-controlled anesthesia was maintained
with 1.5% isoflurane. Two-dimensional cine loops and M-mode
cine loops of the right and left hemi-diaphragms were recorded.
Diaphragm excursion (in mm) was measured from Mmode cine
loops of the right and left hemi-diaphragm. A single operator
imaged all mice.e-specific decellularized scaffolds promote long-term muscle innervation
terialia, https://doi.org/10.1016/j.actbio.2019.03.007
Fig. 1. Gross appearance, morphological, and in vivo functional analyses of treated diaphragms. A Schematic representation of collection and transplantation of biologic and
synthetic patches. B Surgical CDH survival rate. C Gross appearance (thoracic view) and histology (HE: hematoxylin and eosin; MT: Masson’s trichrome) of ePTFE- and dECM-
treated diaphragms at 30 and 90 days postsurgery. Dotted line indicates the applied patch. Arrowhead indicates liver herniation. Asterisk indicates fibrotic capsule. D
Diaphragm thickness analysis; native is for healthy muscle. E Example of ultrasound echography of dECM-treated diaphragm 90 days after surgery. F Treated diaphragm
movement ability measured by ultrasound echography and expressed as percent of excursion with regard to healthy untreated muscles (native). N: native muscle; L: liver;
dE: dECM. Scale bar: 100 lm. ***p < .001; ns: not significant.
C. Trevisan et al. / Acta Biomaterialia xxx (xxxx) xxx 32.5. In silico analyses of the biomechanical response of repaired
diaphragms
We developed different Finite Element Method (FEM)-based
numerical models of mice diaphragms (ABAQUS CAE and Dassault
Systémes). In particular, we obtained a model of a healthy dia-
phragm and two models of diaphragms repaired with ePTFE and
dECM patch according to a computational approach proposed in
a previous work [21]. The model of a healthy diaphragm was
defined using anatomical data and echographic images. For healthy
and repaired diaphragms, we assumed the same geometry (exclud-
ing ePTFE/dECM implant) and the same mechanical properties for
muscle tissue and central tendon (Fig. 2A). Suitable constitutive
models were adopted to describe active/passive mechanical
response of muscle tissue, as well as the passive response of central
tendon and ePTFE/dECM patch. The biomechanical response of
healthy and repaired diaphragms was analyzed for eupnea condi-
tion. Complete methodology is provided in the supplementary
materials.
2.6. Histology and immunofluorescence
Histological and immunofluorescence analyses were performed
on frozen sections (7–10 lm thick) using primary and secondary
antibodies listed in Supplementary Table 1. Complete methodology
is provided in the supplementary materials.
2.7. Real-time PCR
Real-time PCR cycles were performed using a LightCycler II
(Roche, Monza, Italy). Reactions were carried out in triplicate usingPlease cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta BiomaPlatinumTM SYBRTM Green qPCR SuperMix-UDG (Invitrogen) and 2 ml
of primers (Supplementary Table 2), a mix of FW + REV (final con-
centration, 300/300 nM). Complete methodology is provided in the
supplementary materials.
2.8. Mouse phrenic nerve hemi-diaphragm assay and diaphragmatic
muscle function analysis
The assay was performed using treated (n = 3 ePTFE; n = 4
dECM) and untreated hemi-diaphragms. The mouse phrenic nerve
hemi-diaphragm preparation was set up as previously described
[22]; briefly, the diaphragm muscle was dissected with both the
phrenic nerves completely functional and then separated as two
halves; the central tendon was connected to a transducer; each
phrenic nerve was inserted into platinum ring electrodes. In this
setup, cotton wire was connected to the phrenic nerve and passed
through the two platinum rings of the stimulating electrode. Using
a micromanipulator, the electrodes were moved inside the stimu-
lation chamber. Then, the cotton was thread until the phrenic
nerve was in contact with the rings. The nerve was completely
immersed into the solution and placed ideally perpendicular to
the muscle, thus avoiding excessive tension. The electrodes were
not in contact with the muscle to prevent direct stimulation of
muscle fibers. An additional couple of electrodes was inserted
and used to directly stimulate the muscle only at the end of the
nerve stimulation experiment to confirm the force values recorded.
The stimulation parameters were set up as follows: 5 V, 0.1 ms
width, 0.1 Hz for nerve; 30 V, 0.5 ms width, 0.1 Hz for muscle.
To estimate the twitch stress by considering also the size of the
specimen, orientation of the fibers, and position and size of the
possible implant, we developed FEM models of two pairs of testede-specific decellularized scaffolds promote long-term muscle innervation
terialia, https://doi.org/10.1016/j.actbio.2019.03.007
Fig. 2. Modeling of application of ePTFE vs. diaphragm dECM patches. A Finite element model of the mouse diaphragm. Ventral, dorsal, right, and left indicate the anatomical
side. B Diaphragm muscle fiber direction (red arrows) and patch highlighted with dotted ellipse (patch is placed in the left hemi-diaphragm); color map of the diaphragm
displacement along the caudal–cranial direction (mm) at the maximum contraction of the diaphragm in healthy controls those and repaired with ePTFE and dECM patches;
the color bar range is 0.02 mm (blue, minimum displacement) to 1.17 mm (red, maximum displacement). C Diaphragm excursion in the caudal–cranial direction (mm) versus
time (s) of right (dark gray line) and left (light gray line) hemi-diaphragms in healthy and ePTFE- and dECM-treated muscles. The excursion of the hemi-diaphragms is
described by plotting the displacements of the two points shown in figure A. (For interpretation of the references to color in this figure legend, the reader is referred to the
web version of this article.)
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same constitutive models described in Section 2.5 and Supplemen-
tary materials. Sample morphology and size, as well as boundary
conditions, mimicked the setup of the experimental testing. We fit-
ted the numerical response of the models to the experimental data
by iteratively changing the value P0 and the activation function
f aðtÞ – as under isometric conditions, the force–length function f l
and the force–velocity function f v are close to unit (see Supple-
mentary materials for the definition of these parameters). In this
way, the correct twitch force experimentally measured over time
was obtained and the corresponding twitch stress Pt ¼ P0  f aðtÞ
deduced.
2.9. Statistical analysis
All statistical analyses were performed using GraphPad Prism 5
(GraphPad Software). For statistical analysis, unpaired t-tests and
one-way ANOVA (followed by Bonferroni post-hoc test) were used.
All error bars are presented as s.e.m.; *p < 0.05; **p < 0.01;
***p < 0.001.3. Results
3.1. Surgical diaphragm hernia mouse model
A new surgical mouse model of large diaphragm hernia was
established and developed to test the decellularized scaffold as a
new treatment strategy for the repair of defective diaphragms.
After intubation, a 3x5 mm defect was surgically created in the left
hemi-diaphragm to remove approximately 1/3 of the diaphragm. A
hernioplasty was performed with ePTFE or dECM patches stitched
to the residual and pericostal native diaphragm (Supplementary
Fig. 1). Mice treated with ePTFE were used as control, as this pros-
thetic material is commonly used in CDH repair. C57BL/6j mice
were used as donors of dECM patches, whereas BALB/c mice were
chosen as recipients to perform allogeneic transplantation
(Fig. 1A). The overall survival rate of the surgery was 64%. In
Fig. 1B, the survival rate was calculated at 90 days post-
transplantation. A slight, but not significant, improvement in sur-
vival rate after biologic patch application was observed, with 57%
survival in the dECM-treated group and 46% survival in the
ePTFE-treated group.
3.2. Clinical aspects and diaphragm morphological characterization
Twenty percent of the survived ePTFE-treated animals pre-
sented herniation of the liver post-transplantation (Fig. 1C),
whereas none of the dECM-treated mice showed re-herniation.
Macroscopically, no signs of rejection or formation of fibrotic tissue
(deposition of collagen fibers) were detected in dECM-treated dia-
phragms. On the contrary, all the ePTFE-treated animals presented
a capsule of fibrotic tissue around the synthetic scaffolds on both
thoracic and abdominal sides. Histological analyses confirmed
the presence of fibrotic tissue in the control group, with a clear
scarring process around ePTFE patches at both 30 and 90 days post
implantation (Fig. 1C, left). Evident reabsorption of the scaffold was
registered in the dECM-treated group. As expected, dECM patches
were gradually remodeled, hence losing approximately 85% of ini-
tial thickness 90 days after surgery (Fig. 1D), which confirms a
finding previously observed in a scaffold degradation study
in vivo without a diaphragm defect [19]. Nevertheless, this impor-
tant change had no effect on mice diaphragm excursion capacity,
which, by ultrasound analysis, proved to be increasingly efficient,
with no statistical difference with regard to untreated animals
(native) or ePTFE-treated group (Fig. 1E and F). Notably, thePlease cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta BiomaePTFE-treated group presented a wide range of excursion ability
values, with high variability and strong differences among animals.
3.3. In silico analyses of the biomechanical response of repaired
diaphragms
Numerical analyses allowed to better evaluate discrepancies
among ePTFE-treated animals in terms of diaphragm excursion
ability and the difference with the dECM-treated group (Fig. 2A).
The estimated excursion of the diaphragms in eupnea breath cycle
showed that the ePTFE-treated diaphragm had larger asymmetry
than the healthy counterpart (Fig. 2B, bottom). In fact, while the
excursion of the two hemi-diaphragms in healthy muscle was sim-
ilar, the ePTFE-repaired hemi-diaphragm showed a large excursion
decrease, which is estimated in approximately 37% of the healthy
muscle (Fig. 2C). On the contrary, in dECM-treated muscle, this
asymmetry was limited, with a reduction of only approximately
5% in the repaired hemi-diaphragm with regard to healthy dia-
phragm control (Fig. 2C). This behavior can be attributed to the lar-
ger stiffness of ePTFE implant with regard to dECM, although both
have no contractile properties. The large stiffness of ePTFE implant
is also reflected into a reduced change in volume of the pulmonary
cavity. Finally, the last main consequence is the increase of
mechanical stress in the muscle tissue surrounding the implant.
3.4. Analyses of immunoreaction and fibrosis response
Given the differences in the gross appearance of ePTFE- and
dECM-treated diaphragms and the well-known paradigm of for-
eign body reaction on application of synthetic materials [23,24],
we decided to further investigate the local immune response and
fibrogenesis in the treated animals. First, we analyzed cell prolifer-
ation in damaged muscles and evaluated the expression of Ki67
marker, which showed similar levels between the two groups, both
at early and at late time points (Fig. 3A–D, Supplementary Table 3);
this confirms that cell activation was strongly related to the surgi-
cal procedure. The same trend was determined when the general
innate immune reaction was investigated through molecular anal-
ysis of macrophage activation. At early time points, the expression
of several markers of activated macrophages (i.e., Nos2, Arg1, Mrc1,
Il1B, Tnfa, and Tgfb) was uniformly upregulated in both ePTFE- and
dECM-treated diaphragms, thereby highlighting that the surgical
procedure stimulated an initial phase of inflammation and a broad
immune response (Supplementary Fig. 2). Conversely, 15 days
after patch application, the monocyte chemoattractant protein 1
(Mcp1) expression increase was significantly higher in the ePTFE-
treated group than in the dECM-treated group (Fig. 3E). The
Mcp1 expression gradually decreased in both types of treatment
in later time points, reaching the values of untreated samples
(CTRL). This phenomenon was faster and more pronounced in
dECM-treated diaphragms and slower in ePTFE-treated samples.
The overexpression of this soluble factor was associated with the
adhesion and engagement of different types of monocytes/-
macrophages, with the activation of subsequent events of the for-
eign body reaction. We considered the difference in Mcp1
expression levels at 15 days as biologically significant, as this dif-
ference can be related to the higher amount of macrophages
(CD68 + cells) found at both 30 and 90 days in ePTFE-treated sam-
ples, thus indicating a more inflammation when the synthetic
patch was used (Fig. 3A-D; Supplementary Table 3). The resulting
innate immune activation evidenced a strong foreign body reaction
against prosthetic nonresorbable patches. The mechanism of reac-
tion was confirmed by H&E and anti-CTGF (connective tissue
growth factor) staining, that the results of which indicated the
presence of fusing macrophages and giant cells only in the capsule
around ePTFE implants (Fig. 3F).e-specific decellularized scaffolds promote long-term muscle innervation
terialia, https://doi.org/10.1016/j.actbio.2019.03.007
Fig. 3. Immune response, fibrosis, and vascularization after patch implantation. A-C Immunofluorescence of proliferating (Ki67) cells, macrophages (CD68), and laminin in
the treated diaphragms after 30 and 90 days of patch implantation. Nuclei were counterstained with DAPI. B-D Percentage of Ki67 + and CD68 + cells in the treated groups. E
Mcp1 gene expression in treated diaphragms at early time points. F Hematoxylin and eosin stain demonstrated the presence of inflammatory cells in the capsule around
ePTFE; giant cells appeared in the enlargement. Immunofluorescence of CTGF + cells. G TEM of implanted dECM 90 days postsurgery: arrowheads indicate migrated cells from
native muscle inside dECM. H Immunofluorescence of vessels (aSMA) and laminin in treated diaphragms after 90 days and TEM of a representative vessel inside implanted
dECM. Nuclei were counterstained with DAPI. Ctrl: healthy untreated diaphragms. N: native muscle; dE: dECM; L: liver; V: vessel. Where not indicated, scale bar: 100 lm.
Statistical analyses: *p < .05; **p < .01; ns: not significant.
6 C. Trevisan et al. / Acta Biomaterialia xxx (xxxx) xxx3.5. Cell homing and angiogenesis
Formation of an extended vascular network is mandatory to
sustain the integration and growth of an implanted engineered tis-
sue [25]. We previously demonstrated that decellularized dia-
phragm ECM was able to attract different types of cells and
induce angiogenesis [18]. In this new model, cell invasion and for-
mation of new capillaries were analyzed 90 days post-surgery by
transmission electron microscopy (TEM) and immunofluorescence
(Fig. 3G,H). Important changes occurred in the treated diaphragms,
and dECM underwent evident modifications; thus, we used TEM to
analyze in detail some of these transformations (Supplementary
Fig. 3). A remarkable number of cells migrated from the surround-
ing native muscle into the implanted dECM (Fig. 3G and Supple-
mentary Fig. 3A). It was not possible to precisely quantify the
distance covered by the host cells inside the applied patch, but it
was evident that different types of cells were present far fromPlease cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta Biomathe defect edges, and many of the cells were found in the center
of the patch, which suggests a quite complete colonization. Among
these cells, aSMA + cells and completely structured vessels were
found inside the dECM patches 90 days after transplantation
(Fig. 3H and Supplementary Fig. 3B), while no cell homing or
angiogenesis was detected in ePTFE patches.
3.6. Myogenic regeneration
As the main desired ability of a tissue-engineered construct
should be to stimulate host tissue regeneration, we analyzed the
activation of the myogenic pathway at early and late time points.
Gene and protein expression was determined by collecting the
total hemi-diaphragms containing the patches. At early time points
(2, 5, and 15 days), no differences were registered in the upregula-
tion of the analyzed genes Pax7, MyoD, Myf5, and MyoG (Supple-
mentary Fig. 4), thus indicating that the muscle self-regeneratinge-specific decellularized scaffolds promote long-term muscle innervation
terialia, https://doi.org/10.1016/j.actbio.2019.03.007
Fig. 4. Decellularized ECM patch long-termmyogenic activation. A-D Immunofluorescence and Pax7 and MyoD expression in ePTFE- and dECM-treated diaphragms at 30 and
90 days postimplantation. E-G Molecular analyses of early myogenic gene expression (Pax7, Myf5, and MyoD) in treated diaphragms. H-I Molecular analysis and
immunofluorescence against late myogenic cell markers (MyoG and MyH3) and myotubes (MyH3). J Transmission electron microscopy analysis of myofibers (arrowheads)
inside the implanted dECM. Ctrl: healthy untreated diaphragms. N: native muscle; dE: dECM; L: liver. Where not indicated, scale bar: 100 lm. Statistical analyses: *p < .05;
**p < .01; ns: not significant.
C. Trevisan et al. / Acta Biomaterialia xxx (xxxx) xxx 7ability post-injury was independent of the patch used. At late time
points (30 and 90 days post-transplantation), dECM-treated dia-
phragms presented an upregulation of early and late myogenic
markers compared to ePTFE (Fig. 4A–D). Pax7- and MyoD-
positive cells were detected inside dECM (Supplementary Table 3),
while the tissue surrounding containing ePTFE patch resulted
always negative for these two myogenic progenitor markers. This
was confirmed by molecular analyses, where Pax7,Myf5, andMyoD
transcripts were overexpressed in dECM-treated diaphragms with
regard to ePTFE (Fig. 4E–G). The fluctuations in the expression of
Pax7 andMyoD are related to dECM samples because after 90 days,
the expression of stem cell genes and transcription factors also
slowly decreases in this type of treatment. This is a predictable
behavior, as these markers need to reach a balance after a strong
and sustained activation because this also occurs physiologically
after muscle regeneration. Importantly, markers responsible for
skeletal muscle fiber maturation, namely, MyoG and MyH3, were
also significantly upregulated in dECM-treated diaphragms
(Fig. 4H and I) in associated with initial fusion of myogenic progen-
itor cells (Supplementary Fig. 3C) and new muscle fiber formation
inside the dECM scaffold (Fig. 4I and J).Please cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta Bioma3.7. Diaphragm muscle functionality
We then investigated if the local myogenic activation was
linked to the restoration of diaphragm muscle function. Muscle
twitch was analyzed 90 days after ePTFE and dECM patch implan-
tation in a well-established ex vivomodel, the phrenic nerve hemi-
diaphragm assay (Fig. 5A). In this assay, despite the phrenic nerves
being transected and disconnected from the animal’s nervous sys-
tem, their ability to conduct an electrical stimulus was still present.
Indeed, the applied electrodes were conceived to allow a supra-
maximal electrical stimulus that was able to depolarize the phrenic
nerve. From the contact point, the nerve was able to propagate the
depolarization phenomenon and to stimulate the neuromuscular
junction, thereby causing neurotransmitter release and the conse-
quent muscle contraction. The ratio between twitch amplitude
developed by treated and untreated hemi-diaphragms from the
same mouse was taken as a measure of force recovery. The numer-
ical simulation of some experimental tests made it possible to nor-
malize the response of hemi-diaphragms, considering muscle
sample morphology, geometry, and fiber orientation, as well as
shape and size of the applied patch (Fig. 5B and C). In this way,e-specific decellularized scaffolds promote long-term muscle innervation
terialia, https://doi.org/10.1016/j.actbio.2019.03.007
Fig. 5. Diaphragm functionality after patch implantation. A Schematic representation of the experimental mouse phrenic nerve hemi-diaphragm assay system. Electrodes for
phrenic nerve stimulation are used for both control (CTRL) and treated (ePTFE/dECM) diaphragms. B Validation of the FEMmodel through the comparison of CTRL twitch force
estimation (CTRL Estim.) and twitch force experimental data (CTRL Exp. Samples). C Images of a single control hemi-diaphragm (CTRL) and hemi-diaphragm repaired with
biological patch (dECM); black arrowheads indicates the phrenic nerve. FEM models of the two muscle portions, CTRL and dECM, respectively; red arrows show the local
spatial orientation of muscle fibers (not the density). D Twitch force F (mN) acquired with a force transducer versus time (s) produced by the diaphragm portions, repaired
with ePTFE patch and with dECM patch, respectively. The latter two diaphragms are plotted by subtracting the basal force from the total twitch force. The comparison of the
twitch force should be made between treated hemi-diaphragm and contralateral of the same animal. However, the twitch force is affected by contractile properties of muscle
fiber geometry and size of the hemi-diaphragms. A normalization of the twitch force can be obtained using FEM models, as reported in Sections 2.8 and 3.7, to deduce the
twitch stress. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
8 C. Trevisan et al. / Acta Biomaterialia xxx (xxxx) xxxwe estimated more physiological force production in dECM-
treated diaphragms, with twitch stress Pt closer to the untreated
tissue (PECMt ¼ 0:53Pctrlt ), and lower muscle contraction ability was
estimated in ePTFE-treated diaphragms, with an overall reduction
of approximately 65% (PePTFEt ¼ 0:35Pctrlt ; Fig. 5D). This suggested
that decellularized ECM patches were more efficient in sustaining
host tissue regeneration and function recovery, even if the limited
number of cases analyzed and the variance of data did not allow to
find statistically significant difference.
3.8. Nerve attraction and re-growth
Presence of neuromuscular junctions and innervations is an
essential feature of active and functional skeletal muscle tissue
[26,27]. To test whether the force generation in restored dia-
phragm muscles was associated with re-innervation, we investi-Please cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta Biomagated the presence of neuronal marker inside dECM. Schwann
cells are well-known precursors of nerve regeneration [28]; with
the advantage of a mouse model carrying the GFP under the con-
trol of S100 protein, a specific Schwann cell marker, infiltration
of green cells was identified 90 days post-surgery from the sur-
rounding native muscle to the implanted patch (Fig. 6A). To deeply
understand the relationship between Schwann cells and the sur-
rounding tissue, we performed a CLEM (correlative light and elec-
tron microscopy) analysis [29]: using the protocol described in
Supplementary Fig. 5, we selected a group of Schwann cells clearly
located inside the dECM and visualized the same cells at high mag-
nification by TEM (Fig. 6B). This analysis underlined that Schwann
cells were infiltrated inside the implanted patch together with
myogenic cells and other cell types, hence indicating again a situ-
ation of active and complete tissue regeneration (Supplementary
Fig. 6)e-specific decellularized scaffolds promote long-term muscle innervation
terialia, https://doi.org/10.1016/j.actbio.2019.03.007
Fig. 6. Decellularized ECM nerve attraction and re-growth at 90 days post-surgery. A Picture of bright field (BF) and GFP expression of dECM-treated diaphragm at 90 days
post-surgery. Lower panels: enlargement of dashed box, showing Schwann cells inside the implanted patch. B Correlative light and electron microscopy (CLEM) analysis;
fluorescence imaging of a group of Schwann cells migrated in the dECM (left, up); superposition of low-magnification TEM and fluorescence image, scaled to the same
proportions (left, bottom); high magnification (1850x) of the same cells (right). Red stars indicate Schwann cells. C Molecular analysis of GAP43 expression in treated samples.
D Immunofluorescence of ePTFE- and dECM-treated diaphragms; GFP expression indicates the presence of migrated Schwann cells. NF: neurofilament; Bungaro: a–
Bungarotoxin. N: native muscle; dE: dECM; S: Schwann cell. Scale bar: 100 lm. Statistical analyses: * p < .05; ** p < .01; ns: not significant. (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of this article.)
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teristics and properties, we verified in vitro the ability of Schwann
cells to recognize and migrate inside our dECM, a mechanism that
is inhibited when the synthetic patch is used (Supplementary
Fig. 7). Further in vivo analyses demonstrated that there was an
increased expression of growth-associated protein 43 (GAP43), a
specific marker of axonal regeneration, in dECM-treated muscles
compared to ePTFE-treated ones (Fig. 6C). Moreover, immunofluo-
rescence analysis demonstrated the co-expression of neurofilament
and GFP inside the implanted dECM patch (Fig. 6D), suggesting ini-
tial re-innervation from the surrounding tissue toward the dECM.
Importantly, clusters of acetylcholine receptors were also detected
by a– bungarotoxin, which indicates that new neuromuscular junc-
tions could be restored inside the implanted dECM.4. Discussion
Large diaphragmatic hernia in pediatric patients requires the
application of artificial patches to close the congenital defect. The
resulting neo-diaphragm is not elastic and therefore nonfunctional,
and plastic prosthesis does not grow with the child. This situation
leads to hernia recurrences and the need for multiple interven-
tions. Given the current suboptimal methods, we paid attention
on the use of decellularized scaffolds specifically obtained fromPlease cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta Biomathe diaphragmmuscle. The importance of using tissue-specific nat-
urally derived scaffolds to obtain a more precise and committed
regeneration is reported in literature [30,31]. Moreover, several
non-tissue-specific acellular matrices were used to repair CDH
(i.e., PermacolTM, Surgisis, and SIS), and despite their biocompati-
bility and efficiency when used in other tissues, the overall results
in terms of drawbacks, and hernia recurrences were not better
than those of standard PTFE treatment [16,17,32]. In this study,
we showed for the first time the superiority of decellularized dia-
phragm ECM for the closure of a diaphragmatic defect in a new
surgical model of diaphragm hernia, which does not exist in liter-
ature. We aimed to investigate the efficacy of this bioscaffold in
supporting skeletal muscle regeneration with regard to currently
used prosthetic materials, with the prospective of future transla-
tion into clinical practice for the repair of diaphragm defects. We
previously described the desirable structural, biological, and
biomechanical properties of decellularized diaphragm ECM [19].
In this research, we ultimately demonstrated its ability to foster
re-innervation and muscle function recovery.
The first important result obtained upon transplantation of
dECM-derived patches to repair diaphragm defects was the
improvement of clinical outcome with no hernia recurrence
detected, while approximately 20% of ePTFE-treated mice pre-
sented liver herniation. In addition, despite the use of an allograft
dECM, we did not find any sign of rejection after transplantation.e-specific decellularized scaffolds promote long-term muscle innervation
terialia, https://doi.org/10.1016/j.actbio.2019.03.007
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diaphragm-derived ECM is exerted through CD4 + Foxp3 + cell acti-
vation [19]. Another study demonstrated that tissue-derived bio-
material scaffolds enhance the development of a pro-
regenerative immune environment with implication of adaptive
immune cells, specifically mTORC2-dependent CD4 + TH2 T cells,
with inhibition of CD68 + macrophage upregulation [33], data con-
firmed in our diaphragmatic hernia model. On the other side, syn-
thetic patches induced a predictable foreign body reaction, with
consequent fibrosis/fibrous capsule development that was com-
pletely absent when dECM patches were used. The foreign body
reaction is classically characterized by activation of innate immune
response prompted by adhesion of proteins and other biomole-
cules to the surface of the implant, followed by attraction and
fusion of macrophages around the foreign body to form giant cells
[34,35]. This phenotype is accompanied by overexpression of CTGF
and sustained macrophages activation, characteristics that we
found to be significantly upregulated in mice treated with ePTFE
with regard to those with dECM.
Angiogenesis is a mechanism strictly related to the resolution of
the balance between inflammation and muscle regeneration.
Numerous studies have shown that the close interaction among
endothelial, immune and fibro-adipogenic cells, and myogenic pre-
cursors is crucial for good skeletalmuscle regeneration [36–38].We
previously reported that decellularized diaphragm ECM possesses
several cytokines that confer the biologic scaffold the ability to
attract vessels and capillaries in vivo [18]. We confirmed the angio-
genic properties of decellularized diaphragm ECM also in ourmodel
of diaphragm hernia, with a–SMA+ cells and vessels found only
inside implanted dECM and not in ePTFE implants, where just little
capillaries were noticed in the surrounding fibrotic capsule. This
definitely demonstrated that diaphragm-derived scaffolds could
be efficiently re-vascularized once implanted in vivo.
Activation of efficient local muscle regeneration is a critical out-
come of our tissue engineering approach for a complete functional
correction of the diaphragm defect. In our mouse model, the surgi-
cal injury initially activated a self-regeneration mechanism, which
then persisted long term only in dECM-treated animals. In fact, dia-
metrically opposite results were obtained in terms of myogenic
pathway activation between ePTFE and dECM implants. Tissue-
specific dECM scaffolds were able to induce the entire myogenic
program, from activation of Pax7+ stem cells to the formation of
myofibers, indicated by the expression of MyH3, a specific marker
of newly generated fibers. This process was completely absent in
ePTFE-treated diaphragms. This result is of paramount importance,
as the regeneration evoked by tissue-specific dECM recapitulates
the physiological pathway and,most importantly, persists for a long
period, re-enforcing new tissue formation. This strong activation of
muscle regeneration translated into an overall amelioration of
diaphragmatic function. Using the ex vivo model of phrenic nerve
hemi-diaphragm assay, we highlighted the specific contractile
capacities of the diaphragmaticmuscle after surgery. In this system,
only dECM-treated diaphragms presented a good twitch force
recovery after damage, and importantly, the experimental result
was robustly supported by numerical analysis, hence aiming at nor-
malizing treated hemi-diaphragms to the corresponding untreated
counterpart to reduce physiological interindividual variation.
It is known from the literature that restoration of muscle func-
tion is strongly related to efficient re-innervation of the trans-
planted construct [39–41]. Re-innervation of muscle fibers in the
injured tissue and in transplanted muscle explants can take long
time to occur [42], and exercise has been proposed to improve
and accelerate muscle function following skeletal muscle injuries
[27,30]. On the basis of these suggestions, we hypothesized that
a regime of indispensable exercise, as it occurs in the diaphragm
muscle, could naturally enhance and stimulate nerve attraction.Please cite this article as: C. Trevisan, E. Maghin, A. Dedja et al., Allogenic tissu
and functional recovery in a surgical diaphragmatic hernia model, Acta BiomaIndeed, we found GFP+ Schwann cells migrating from the sur-
rounding muscle tissue to implanted dECM patches. In the periph-
eral nervous system, Schwann cells produce the myelin sheath, and
myelinated Schwann cells can dedifferentiate and drive the regen-
eration of peripheral axons upon nerve injury [28,43]. This regen-
eration is strongly related to biologic and biomechanical properties
of the ECM surrounding the injured nerve [44,45]. We observed
that in our model, Schwann cells easily recognized the implanted
biologic patch, thereby promoting their migration inside the scaf-
fold and initial nerve regeneration. This phenomenon is also influ-
enced by the ability of myogenic cells to migrate and form new
muscle fibers inside the patch, as it is reported in the literature that
muscle fibers can sense whether or not they are innervated and
respond to denervation by enhancing their susceptibility to re-
innervation [46,47]. At the same time, formation of neuromuscular
junctions inside the implanted scaffold, as indicated by the pres-
ence of neurofilament and a–bungarotoxin staining, ensured and
fostered a continuous maturation of the skeletal muscle compart-
ment [48], establishing a long-lasting positive loop between mus-
cle and the nervous system.
Despite the positive clinical outcome and general functional
recovery at 90 days post-transplantation, dECM patches did not
activate complete defect regeneration. This was probably due to
a persistent imbalance between dECM remodeling and skeletal
muscle regeneration, a limit that could be overcome with different
kinds of dECM functionalization [49], from loading of selected
growth factors for massive recruitment of muscle (stem) cells to
the in vitro cell engineering of the biologic scaffolds with appropri-
ate progenitors before in vivo implantation [30].
5. Conclusion
In conclusion, we believe that these results lay a solid pillar for
the tissue engineering approaches for the treatment of CDH,
thereby identifying tissue-specific diaphragm-derived ECM as key
player in future preclinical studies on large animal models.
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